Baillie Gifford & CO Abcam PLC Transaction History

Baillie Gifford & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.54 - $24.41 $18.2 Million - $20.6 Million	-844,252 Reduced 10.36%	7,307,800 $165 Million
Q2 2023 Jul 28, 2023	SELL	$12.62 - $24.47 $47.6 Million - $92.2 Million	-3,768,239 Reduced 31.61%	8,152,052 $199 Million
Q1 2023 May 03, 2023	SELL	$12.98 - $17.1 $3.16 Million - $4.16 Million	-243,458 Reduced 2.0%	11,920,291 $160 Million
Q4 2022 Jan 24, 2023	BUY	$13.92 - $17.0 $169 Million - $207 Million	12,163,749 New	12,163,749 $189 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.